PAGANINI, CLAUDIA
PAGANINI, CLAUDIA
Blastic Plasmacytoid Dendritic Cell Neoplasm, from a Dermatological Point of View
2024-01-01 Di Raimondo, C; Lozzi, F; Di Domenico, Pp; Paganini, C; Campione, E; Galluzzo, M; Bianchi, L
Characterization of Super-Responder Profile in Chronic Plaque Psoriatic Patients under Guselkumab Treatment: A Long-Term Real-Life Experience
2024-01-01 Marcelli, L; Belcastro, A; Talamonti, M; Paganini, C; Fico, A; Savastano, L; Di Raimondo, C; Vellucci, L; Bianchi, L; Galluzzo, M
Deucravacitinib, a selective tyrosine kinase 2 inhibitor, for the treatment of moderate-to-severe plaque psoriasis
2023-01-01 Galluzzo, M; Vellucci, L; Marcelli, L; Paganini, C; Bianchi, L; Talamonti, M
Dupilumab for Treatment of Prurigo Nodularis: Real-Life Effectiveness for up to 84 Weeks
2024-01-01 Paganini, C; Talamonti, M; Maffei, V; Di Raimondo, C; Bianchi, L; Galluzzo, M
Eczematous liraglutide eruption managed by dupilumab: A case report
2024-01-01 Paganini, C; Belcastro, A; Fico, A; Talamonti, M; Bianchi, L; Galluzzo, M
Efficacy and Safety of Dupilumab in the Treatment of Hand Eczema: A Retrospective Study
2024-03-24 Paganini, C; Maffei, V; Vellucci, L; Talamonti, M; Petruzzellis, A; Le Pera, L; DI RAIMONDO, C; Bianchi, L; Galluzzo, M
Evaluating the Clinical Meaning of Dermatology Life Quality Index Scores Between Different Phenotypes of Atopic Dermatitis in Patients Before and After Biologic Therapy With Dupilumab
2024-01-01 Russo, F; Cioppa, V; Lazzeri, L; Milanesi, N; Galluzzo, M; D'Erme, Am; Schettini, N; Cocuroccia, B; Sordi, D; Panebianco, A; Talamonti, M; Paganini, C; De Pità, O; Giampetruzzi, Ar; Scaglione, Gl
Guselkumab for treatment of moderate-to-severe plaque psoriasis: real-life effectiveness and drug-survival for up to 148 weeks
2023-01-01 Galluzzo, M; Marcelli, L; Vellucci, L; Paganini, C; Maffei, V; Tofani, L; Belcastro, A; Bianchi, L; Talamonti, M
Impact of Upadacitinib on Atopic Keratoconjunctivitis Exacerbated by Dupilumab Treatment in Atopic Dermatitis Patients: A Prospective Dermatological and Ophthalmological Clinical Evaluation in Common Clinical Practice
2024-01-01 Paganini, C; Spelta, S; Tofani, L; Talamonti, M; Bianchi, L; Coassin, M; Di Zazzo, A; Galluzzo, M
letter in response to the case report: “recalcitrant generalized granuloma annulare treated successfully with dupilumab”
2023-01-01 Paganini, C; Talamonti, M; Campione, E; Bianchi, L; Galluzzo, M
Long-Term Persistence Rate of Secukinumab in Psoriatic Patients: A Six-Year Multicenter, Real-World Experience, Retrospective Study
2024-01-01 Galluzzo, M; Trovato, E; Talamonti, M; Caldarola, G; Di Nardo, L; Lazzeri, L; Mugheddu, C; Burlando, M; Balestri, R; Bernardini, N; Biondi, G; Vellucci, L; Russo, F; De Simone, C; Paganini, C; Rech, G; Cozzani, Ec; Atzori, L; Montesu, Ma; Potenza, C; Chiricozzi, A; Rubegni, P
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2024 | Blastic Plasmacytoid Dendritic Cell Neoplasm, from a Dermatological Point of View | Di Raimondo, C; Lozzi, F; Di Domenico, Pp; Paganini, C; Campione, E; Galluzzo, M; Bianchi, L | Articolo su rivista | |
| 1-gen-2024 | Characterization of Super-Responder Profile in Chronic Plaque Psoriatic Patients under Guselkumab Treatment: A Long-Term Real-Life Experience | Marcelli, L; Belcastro, A; Talamonti, M; Paganini, C; Fico, A; Savastano, L; Di Raimondo, C; Vellucci, L; Bianchi, L; Galluzzo, M | Articolo su rivista | |
| 1-gen-2023 | Deucravacitinib, a selective tyrosine kinase 2 inhibitor, for the treatment of moderate-to-severe plaque psoriasis | Galluzzo, M; Vellucci, L; Marcelli, L; Paganini, C; Bianchi, L; Talamonti, M | Articolo su rivista | |
| 1-gen-2024 | Dupilumab for Treatment of Prurigo Nodularis: Real-Life Effectiveness for up to 84 Weeks | Paganini, C; Talamonti, M; Maffei, V; Di Raimondo, C; Bianchi, L; Galluzzo, M | Articolo su rivista | |
| 1-gen-2024 | Eczematous liraglutide eruption managed by dupilumab: A case report | Paganini, C; Belcastro, A; Fico, A; Talamonti, M; Bianchi, L; Galluzzo, M | Articolo su rivista | |
| 24-mar-2024 | Efficacy and Safety of Dupilumab in the Treatment of Hand Eczema: A Retrospective Study | Paganini, C; Maffei, V; Vellucci, L; Talamonti, M; Petruzzellis, A; Le Pera, L; DI RAIMONDO, C; Bianchi, L; Galluzzo, M | Articolo su rivista | |
| 1-gen-2024 | Evaluating the Clinical Meaning of Dermatology Life Quality Index Scores Between Different Phenotypes of Atopic Dermatitis in Patients Before and After Biologic Therapy With Dupilumab | Russo, F; Cioppa, V; Lazzeri, L; Milanesi, N; Galluzzo, M; D'Erme, Am; Schettini, N; Cocuroccia, B; Sordi, D; Panebianco, A; Talamonti, M; Paganini, C; De Pità, O; Giampetruzzi, Ar; Scaglione, Gl | Articolo su rivista | |
| 1-gen-2023 | Guselkumab for treatment of moderate-to-severe plaque psoriasis: real-life effectiveness and drug-survival for up to 148 weeks | Galluzzo, M; Marcelli, L; Vellucci, L; Paganini, C; Maffei, V; Tofani, L; Belcastro, A; Bianchi, L; Talamonti, M | Articolo su rivista | |
| 1-gen-2024 | Impact of Upadacitinib on Atopic Keratoconjunctivitis Exacerbated by Dupilumab Treatment in Atopic Dermatitis Patients: A Prospective Dermatological and Ophthalmological Clinical Evaluation in Common Clinical Practice | Paganini, C; Spelta, S; Tofani, L; Talamonti, M; Bianchi, L; Coassin, M; Di Zazzo, A; Galluzzo, M | Articolo su rivista | |
| 1-gen-2023 | letter in response to the case report: “recalcitrant generalized granuloma annulare treated successfully with dupilumab” | Paganini, C; Talamonti, M; Campione, E; Bianchi, L; Galluzzo, M | Articolo su rivista | |
| 1-gen-2024 | Long-Term Persistence Rate of Secukinumab in Psoriatic Patients: A Six-Year Multicenter, Real-World Experience, Retrospective Study | Galluzzo, M; Trovato, E; Talamonti, M; Caldarola, G; Di Nardo, L; Lazzeri, L; Mugheddu, C; Burlando, M; Balestri, R; Bernardini, N; Biondi, G; Vellucci, L; Russo, F; De Simone, C; Paganini, C; Rech, G; Cozzani, Ec; Atzori, L; Montesu, Ma; Potenza, C; Chiricozzi, A; Rubegni, P | Articolo su rivista |